146 related articles for article (PubMed ID: 10364585)
1. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods.
Cantón E; Pemán J; Carrillo-Muñoz A; Orero A; Ubeda P; Viudes A; Gobernado M
J Clin Microbiol; 1999 Jul; 37(7):2197-200. PubMed ID: 10364585
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
Espinel-Ingroff A; Rodríguez-Tudela JL; Martínez-Suárez JV
J Clin Microbiol; 1995 Dec; 33(12):3154-8. PubMed ID: 8586692
[TBL] [Abstract][Full Text] [Related]
4. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
González GM; Elizondo M; Ayala J
J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
Ruhnke M; Schmidt-Westhausen A; Trautmann M
Mycoses; 1996; 39 Suppl 2():47-50. PubMed ID: 9198745
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
Patterson TF; Kirkpatrick WR; Revankar SG; McAtee RK; Fothergill AW; McCarthy DI; Rinaldi MG
J Clin Microbiol; 1996 Dec; 34(12):3237-9. PubMed ID: 8940483
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.
Pfaller MA; Messer SA; Karlsson A; Bolmström A
J Clin Microbiol; 1998 Sep; 36(9):2586-9. PubMed ID: 9705397
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
Mokaddas EM; Al-Sweih NA; Khan ZU
J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
12. Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species.
Morace G; Amato G; Bistoni F; Fadda G; Marone P; Montagna MT; Oliveri S; Polonelli L; Rigoli R; Mancuso I; La Face S; Masucci L; Romano L; Napoli C; Tatò D; Buscema MG; Belli CM; Piccirillo MM; Conti S; Covan S; Fanti F; Cavanna C; D'Alò F; Pitzurra L
J Clin Microbiol; 2002 Aug; 40(8):2953-8. PubMed ID: 12149358
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
14. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
15. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole.
Sewell DL; Pfaller MA; Barry AL
J Clin Microbiol; 1994 Sep; 32(9):2099-102. PubMed ID: 7814531
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Kronvall G; Karlsson I
J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
18. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
[TBL] [Abstract][Full Text] [Related]
19. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.
Arthington-Skaggs BA; Lee-Yang W; Ciblak MA; Frade JP; Brandt ME; Hajjeh RA; Harrison LH; Sofair AN; Warnock DW;
Antimicrob Agents Chemother; 2002 Aug; 46(8):2477-81. PubMed ID: 12121921
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.
Arthington-Skaggs BA; Warnock DW; Morrison CJ
Antimicrob Agents Chemother; 2000 Aug; 44(8):2081-5. PubMed ID: 10898679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
